Global

‡ In these countries please contact our distributor

Introducing DURAFIBER Ag

DURAFIBER - now available in Ag.

The expanded DURAFIBER range gives you greater choice when treating flat or cavity wounds including leg ulcers, pressure ulcers, diabetic ulcers and surgical wounds.  With its unique blend of fibres, DURAFIBER provides a combination of clinical benefits that support patients as well as budgets.

DURAFIBER is a highly absorbent1, non-woven gelling fibre dressing for the management of medium to heavily exuding chronic and acute wounds.  When DURAFIBER comes into contact with exudate its unique dressing technology causes the individual fibres to swell as they absorb wound fluid to form a soft cohesive gel sheet.  As a result the excess exudate and any harmful bacteria it may contain are locked within the gelled dressing structure1,7.

With the introduction of DURAFIBER Ag, you can now use DURAFIBER on wounds where there are signs and symptoms of infection.

For patients who are living with a chronic wound it is an uncomfortable and distressing experience.  DURAFIBER is designed to promote healing and aims to improve your patient’s wellbeing by:

  • Supporting patient comfort with one piece removal1-6
  • Providing sustained antimicrobial activity to reduce signs of infection5,8,9 (DURAFIBER Ag only)
  • Aiding protection of the peri wound area and helping to reduce the risk of maceration5,10
  • Effectively managing exudate through the high absorption and retention capacity1,2,4,11  whilst maintaining a favourable moist wound environment1,12

DURAFIBER and DURAFIBER Ag come in a range of sizes and are available to order now through Drug Tariff and NHS Supply Chain.

Click here to find out more about the DURAFIBER range.

References

1. Smith & Nephew Report DS/10/056/R1 05 2010. DURAFIBER Dressing Physical Properties. (in-vitro)
2. Smith & Nephew Data on file report DS/11/187. Testing Performed as Part of DURAFIBER Photo Shoot. (in-vitro)
3. Case Series Evaluation: The Use of DURAFIBER on Exuding Wounds. Wounds UK 2012, Vol 8, No 3.
4. Smith & Nephew Wound Management Laboratory Report DS/10/060/R1. DURAFIBER Ag Dressing Physical Properties, Dowler A, September 2010. (in-vitro)
5. Smith & Nephew Wound Management Data on file report OR- DOF/28. A prospective, open, multicentre study to evaluate a new fibrous silver dressing in the treatment of moderate to highly exuding chronic wounds, Rafiq G, Fenton S. January 2013.
6. Smith & Nephew Wound Management Data on file report DS/12/093/DOF. Integrity Testing of DURAFIBER Ag in horse serum and ionic solution, Dowler A, April 2012. (in-vitro)
7. Smith & Nephew Wound Management Data on file report 1004001 04 2010, Lumb H, Visual Demonstration of sequestration of Pseudomonas aeruginosa and Staphylococcus aureaus in a DURAFIBER dressing using confocal microscopy (in-vitro)
8. Smith & Nephew Wound Management Data on file report 1004007. Antimicrobial activity of DURAFIBER Ag against bacteria, yeast and fungi commonly found in wounds over a 7 day period, Woodmansey E, April 2010. (in-vitro)
9. Smith & Nephew Wound Management Data on file report 1009012. Antimicrobial activity of DURAFIBER Ag against bacteria, yeast and fungi commonly found in wounds over a 7 day period, Vaughan KL, McMillan J, Lumb H and Woodmansey E,September 2010. (in-vitro)
10. Smith & Nephew Wound Management Data on file report DS/12/108/DOF.Testing on lateral wicking of DURAFIBER Ag dressings, Dowler A, April 2012. (in-vitro)
11. Smith & Nephew Wound Management Laboratory Report Reference DS/12/109/DOF, Testing on Absorption of DURAFIBER Ag during compression, Dowler A, April 2012. (in-vitro)
12. The Clinical and Physical Properties of DURAFIBER Ag, the Moist Wound Environment and the Autolytic Debridement, Myers D, July 2012. (in-vitro)
13. World Union of Wound Healing Societies (WUWHS) Principles of best practice. Wound exudate and the role of dressings. A consensus document London MED Ltd. 2007.

Patients

Smith & Nephew is providing information in this site for general educational use only, and does not intend for this to be construed as medical advice or used as a substitute for the advice of your physician. For questions or concerns about a previous or upcoming surgery, Smith & Nephew recommends that you contact your healthcare professional.